bpc-157 fda warning letter compounding issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA warning letters target marketers

A lot/batch identifier is recorded on the product label where available and corresponds to the COA shown on this page

If new spider veins appear, additional treatments may be necessary in the future

They can provide relief but often come with serious side effects like infections, weight gain, mood swings, and bone loss

What the animal studies cannot tell us includes optimal human dosing, population-specific responses (elderly, children, pregnancy), long-term safety in humans, rare side effects that require large sample sizes to detect, and interactions with medications or medical conditions

Sophisticated peptide therapy requires ongoing partnership, not one-time advice